News Quantified

YMAB – y-mabs therapeutics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Yahoo Finance [Yahoo! Finance]

Y-mAbs to Present at the 43rd Annual J.P. Morgan Healthcare Conference

We're Hopeful That Y-mAbs Therapeutics (NASDAQ:YMAB) Will Use Its Cash Wisely [Yahoo! Finance]

Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) had its "buy" rating re-affirmed by analysts at HC Wainwright.

Y-mAbs Presents SADA Platform Preclinical Data and Trial in Progress Posters at the 2024 American Society Hematology (ASH) Annual Meeting [Yahoo! Finance]

-4.7%

MISS

-23.5%

MISS

-20.9%

MISS

11.9%

BEAT

Oppenheimer Holdings Inc.

Form SC 13G/A Y-mAbs Therapeutics, Filed by: Paradigm Biocapital Advisors LP

Form SC 13G/A Y-mAbs Therapeutics, Filed by: VANGUARD GROUP INC

Form 10-Q Y-mAbs Therapeutics, For: Sep 30

Form 8-K Y-mAbs Therapeutics, For: Nov 08

Form SC 13G/A Y-mAbs Therapeutics, Filed by: VANGUARD GROUP INC

Top News Gainers

3/19 Form 4 Y-mAbs Therapeutics, For: Mar 17 Filed by: Moller-San Pedro Claus Juan 22.2%

3/18 Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 10.2%

3/13 YmAbs Therapeutics, Inc. (YMAB) Q4 2019 Earnings Call Transcript [The Motley Fool] 9.7%

3/24 Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 9.3%

1/15 Form 4 Y-mAbs Therapeutics, For: Jan 13 Filed by: Gad Thomas 9.1%

10/31 Form 8-K Y-mAbs Therapeutics, For: Oct 29 7.9%

4/21 Form 8-K Y-mAbs Therapeutics, For: Apr 15 5.8%

5/14 Form 4 Y-mAbs Therapeutics, For: May 13 Filed by: Gad Thomas 5.7%

6/8 Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 5.2%

1/22 Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 5.2%

Top News Decliners

7/1 Form 8-K Y-mAbs Therapeutics, For: Jul 01 -21.3%

3/14 Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -16.7%

10/29 Y-mAbs Announces Proposed Public Offering of Common Stock -10.1%

5/10 Q1/2019 3/31/2019 EPS -0.470 ZacksConsensus N/A ActVsEst N/A - N/A -10.0%

3/5 Y-mAbs to Announce 2019 Financial and Operating Results on March 12, 2020 -8.7%

6/15 Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) had its "hold" rating re-affirmed by analysts at Zacks Investment Research. -6.9%

8/3 Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $26.00 price target on the stock. -6.1%

2/27 Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -5.7%

11/1 Form 8-K Y-mAbs Therapeutics, For: Oct 31 -5.6%

10/12 Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) had its "hold" rating re-affirmed by analysts at Zacks Investment Research. -5.1%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day